(Q26864616)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Peter Bannas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

18 July 2014

1 reference

World journal of orthopedics

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

272-282

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

Non-secretory myeloma: a clinician's guide

12 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Management of older adults with multiple myeloma

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Evolving role of FDG PET/CT in multiple myeloma imaging and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Differentiation of myeloma and metastatic cancer in the spine using dynamic contrast-enhanced MRI.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

The role of imaging techniques in the management of multiple myeloma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Advances in imaging and the management of myeloma bone disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Imaging of Extraosseous Myeloma: CT, PET/CT, and MRI Features

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Role of MRI for the diagnosis and prognosis of multiple myeloma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.

28 September 2017

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Modern imaging techniques in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Impact of a 4th generation iterative reconstruction technique on image quality in low-dose computed tomography of the chest in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Multiple myeloma: MR patterns of response to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Whole-Body MRI versus PET in assessment of multiple myeloma disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

(11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Clinical value of ¹¹C-methionine PET/CT in patients with plasma cell malignancy: comparison with ¹⁸F-FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

¹⁸F-FAMT in patients with multiple myeloma: clinical utility compared to ¹⁸F-FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Whole-body (18)F-FDG PET identifies high-risk myeloma.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4095020

Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)

28 November 2018

1 reference

https://api.crossref.org/works/10.5312%2FWJO.V5.I3.272

The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma

21 January 2018

1 reference

12 December 2020

Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma

1 reference

12 December 2020

Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates

1 reference

12 December 2020

MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images

1 reference

12 December 2020

Value of 18F-fluorodeoxyglucose uptake in positron emission tomography/computed tomography in predicting survival in multiple myeloma

1 reference

12 December 2020

The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma

1 reference

12 December 2020

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

1 reference

12 December 2020

F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma

1 reference

12 December 2020

Evaluation of serial bone X-ray examination in multiple myeloma

1 reference

12 December 2020

Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging

1 reference

12 December 2020

Response Assessment in Patients with Multiple Myeloma during Antiangiogenic Therapy using Arterial Spin Labeling and Diffusion-Weighted Imaging

1 reference

12 December 2020

18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation

1 reference

12 December 2020

Magnetic resonance imaging in the staging of solitary plasmacytoma of bone

1 reference

12 December 2020

Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma

1 reference

12 December 2020

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation

1 reference

12 December 2020

The impact of extramedullary disease at presentation on the outcome of myeloma

1 reference

12 December 2020

The radiological demonstration of osseous metastases. Experimental observations

1 reference

12 December 2020

Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results

1 reference

12 December 2020

Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications

1 reference

12 December 2020

[Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results]

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.5312/WJO.V5.I3.272

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

PubMed publication ID

25035830

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035830%20AND%20SRC:MED&resulttype=core&format=json